Trial Profile
A trial of angiogenesis genotyping, LDH serum level and treatment efficacy for advanced hepatocellular carcinoma patients receiving sorafenib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 11 Dec 2015 New trial record